GSBR-1290

· Gasherbrum Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSBR-1290, covering 2024-04-25 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus [Phase 1, Phase 2]

See pricing